NCT07189897View on ClinicalTrials.gov

Apixaban or Enoxaparin After Head and Neck Cancer Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

September 30, 2027

Study Completion Date

December 31, 2027

Conditions
Venous ThromboembolismHead and Neck Cancer
Interventions
DRUG

Enoxaparin

For DVT prophylaxis

DRUG

Apixaban

For DVT prophylaxis

Trial Locations (1)

13210

RECRUITING

SUNY Upstate, Syracuse

All Listed Sponsors
collaborator

State University of New York - Upstate Medical University

OTHER

lead

Kiranya Arnold

OTHER